respiratori
virus
respiratori
syncyti
viru
rsv
rhinoviru
rv
influenza
viru
iv
frequent
caus
upper
urti
lower
respiratori
tract
infect
lrti
infect
includ
common
cold
pneumonia
bronchiti
bronchiol
direct
indirect
cost
associ
viral
respiratori
tract
infect
iv
add
billion
annual
usa
annual
burden
due
iv
epidem
estim
around
billion
usa
season
iv
epidem
affect
billion
global
popul
caus
half
million
death
everi
year
viral
aetiolog
found
common
cold
case
rv
alon
account
furthermor
rv
detect
patient
hospit
sever
communityacquir
pneumonia
ie
often
iv
streptococcu
pneumonia
studi
especi
children
adult
year
age
chronic
ill
high
risk
develop
sever
diseas
upon
lrti
acut
lrti
one
major
caus
childhood
mortal
worldwid
rsv
iv
among
main
pathogen
caus
acut
lrti
children
year
least
million
case
acut
million
case
sever
acut
lrti
annual
viral
rti
especi
rv
infect
frequent
caus
chronic
obstruct
pulmonari
diseas
copd
asthma
exacerb
respiratori
virus
also
implic
develop
persist
asthma
well
initi
autoimmun
diseas
despit
larg
impact
societi
treatment
viral
infect
mostli
support
discuss
respiratori
virusinduc
adapt
heterolog
immun
mechan
infect
autoimmun
asthma
specif
describ
publish
data
involv
viru
strain
implic
tb
cell
epitop
final
outcom
among
other
better
understand
heterolog
immun
hi
potenti
lead
new
therapeut
prevent
strategi
rang
immunolog
mediat
disord
hi
alter
immun
respons
toward
antigen
result
preced
encount
unrel
antigen
thu
immun
memori
central
requir
hi
therefor
heterolog
immun
respons
exclus
link
adapt
immun
system
howev
recent
year
innat
immun
memori
describ
vaccin
associ
substanti
innat
heterolog
effect
heterolog
innat
immun
stimul
way
alter
adapt
immun
respons
toward
antigen
involv
induct
toler
th
polar
substitut
break
toler
enhanc
adapt
immun
cell
respons
maintain
antigen
specif
see
fig
b
cell
shown
mediat
heterolog
effect
antibodi
shown
protect
heterolog
viru
challeng
hand
antibodi
induc
viral
infect
contribut
autoimmun
diseas
possibl
play
role
alloreact
evid
suggest
cell
receptor
tcr
crossreact
common
respiratori
virus
also
shown
unrel
virus
even
virus
microbi
speci
crossreact
cell
shown
protect
heterolog
viru
challeng
furthermor
pathogenderiv
mimic
tumorassoci
antigen
abl
enhanc
cell
respons
toward
tumor
antigen
therefor
pathogenderiv
epitop
might
use
tumor
vaccin
hi
also
detriment
effect
host
exampl
preexist
memori
tm
cell
restrict
prime
protect
cell
heterolog
antigen
furthermor
preexist
tm
cell
narrow
primari
cell
respons
shift
toward
prolifer
high
affin
clone
narrow
cell
respons
may
lead
escap
variant
shown
associ
sever
diseas
progress
furthermor
virusmedi
tcr
crossreact
also
shown
involv
allo
well
autoantigen
crossreact
cell
contribut
transplant
reject
mani
although
case
unspecif
activ
tm
cell
also
associ
hi
set
differ
mechan
suggest
unspecif
cell
activ
eg
type
interferon
ifn
type
ii
ifn
signal
fig
bystand
activ
tm
cell
contribut
earli
pathogen
control
tissu
resid
memori
trm
cell
import
role
pathogen
clearanc
lung
sinc
trm
stay
site
infect
pathogen
clearanc
provid
rapid
protect
upon
homolog
viru
challeng
mice
human
lung
trm
shown
protect
heterosubtyp
iv
challeng
mice
note
hi
may
alter
immunodomin
induc
chang
th
polaris
result
loss
specif
tm
cell
addit
heterolog
immun
respons
necessarili
reciproc
cell
equip
tcr
sens
cognat
antigen
major
histocompat
complex
mhc
molecul
present
peptid
antigen
cell
form
peptidemhc
pmhc
complex
mhc
molecul
present
peptid
mer
length
mhc
class
ii
molecul
abl
present
even
longer
peptid
estim
number
diverg
tcr
human
nativ
cell
pool
wherea
number
potenti
foreign
peptid
present
mhc
molecul
suggest
taken
togeth
broad
tcr
crossreact
inevit
suffici
immun
protect
theori
support
find
one
tcr
abl
recogn
million
differ
peptid
present
one
mhc
molecul
crossreact
common
peptid
high
degre
sequenc
homolog
also
peptid
littl
homolog
abl
elicit
crossreact
immun
respons
moreov
tcr
crossreact
restrict
peptid
length
present
via
mhc
class
crossrecognit
seemingli
nonrel
peptid
might
occur
due
hotspot
bind
peptidetcr
interact
focus
hotspot
toler
substitut
posit
b
plasma
cell
contribut
host
protect
produc
antibodi
neutral
pathogen
andor
toxin
recognit
antigen
occur
bind
cleft
antibodi
locat
fragment
antigen
bind
fab
domain
bind
cleft
contain
multipl
paratop
recogn
b
cell
epitop
antigen
therefor
antibodi
potenti
polyspecif
might
necessari
provid
suffici
immun
protect
major
pathogen
b
cell
epitop
constitut
amino
acid
averag
contrast
tscell
epitop
conform
discontinu
epitop
addit
hotspot
recognit
also
like
antibodyantigen
interact
middl
east
respiratori
syndrom
mer
cov
sever
acut
respiratori
syndrom
sar
cov
caus
recurr
epidem
associ
high
mortal
cell
well
antibodi
suggest
protect
effect
sarscov
infect
humor
crossreact
sar
merscov
absent
sever
studi
recent
tai
et
al
show
immun
mice
recombin
receptor
bindingdomain
rrbd
spike
protein
differ
merscov
strain
induc
broadli
neutral
antibodi
human
camel
merscov
intranas
vaccin
viral
vaccin
vector
encod
conserv
sarscov
cell
epitop
protect
mice
homolog
heterolog
challeng
merscov
protect
depend
crossreact
cell
produc
cell
gener
preced
iv
infect
vaccin
abl
provid
protect
heterosubtyp
iv
infect
human
mice
cell
crossstrain
protect
due
recognit
conserv
iv
protein
season
iv
vaccin
gener
strainspecif
neutral
antibodi
ha
na
fail
induc
signific
crossreact
respons
therefor
major
goal
develop
iv
vaccin
induc
crossreact
cell
andor
antibodi
respons
one
target
might
immunodomin
human
leukocyt
antigen
hla
epitop
conserv
strain
mani
year
although
mutat
detect
valkenburg
et
al
show
cell
also
recogn
three
natur
occur
variant
addit
tem
cell
unexpos
adult
lyse
iv
pandem
infect
cell
ex
vivo
therefor
potenti
target
broadli
iv
protect
vaccin
primeboost
vaccin
licenc
live
attenu
influenza
vaccin
laiv
confer
enhanc
protect
heterosubtyp
iv
challeng
compar
fluzon
control
protect
depend
cell
also
protect
heterosubtyp
challeng
addit
season
laiv
vaccin
induc
lung
trm
cell
mice
mice
protect
heterosubtyp
challeng
week
laiv
vaccin
also
shown
boost
preexist
crossreact
cell
vaccin
children
vaccin
selfamplifi
mrna
glaxosmithklin
london
uk
lipid
nanoparticl
encod
conserv
intern
iv
protein
nucleoprotein
np
andor
matrix
protein
induc
prolifer
np
cell
well
cell
mice
vaccin
mice
surviv
heterosubtyp
iv
challeng
evid
suggest
innat
immun
stimul
lead
broader
adapt
immun
respons
tolllik
receptor
agonist
togeth
split
iv
vaccin
vaccin
alon
protect
mice
homolog
heterolog
viru
challeng
heterolog
effect
depend
cell
specif
ha
consist
highli
variabl
globular
head
domain
main
target
antibodi
respons
stalkstem
domain
stalk
domain
highli
conserv
among
two
group
iv
antistalk
antibodi
occur
lower
titer
less
frequent
antihead
antibodi
infrequ
induc
inactiv
iv
vaccin
inactiv
vaccin
show
averag
fourfold
antistalk
antibodi
increas
human
first
immun
differ
approach
stalk
vaccin
investig
hold
promis
univers
iv
vaccin
comput
optim
broadli
reactiv
antigen
cobra
vaccin
ha
head
domain
potenti
gener
broadli
protect
antibodi
season
pandemicderiv
cobra
broadest
hai
activ
inocul
mice
use
viruslik
particl
vlp
vaccin
induc
broadlyreact
antibodi
protect
mice
challeng
anoth
approach
overcom
strainspecif
immun
vaccin
contain
highli
conserv
extracellular
domain
iv
matrix
protein
mani
differ
vlp
use
enhanc
otherwis
low
immunogen
differ
vaccin
induc
antibodi
also
cell
protect
heterolog
viru
challeng
mice
furthermor
lung
trm
cell
mediat
long
live
month
heterolog
protect
mice
differ
monoclon
antibodi
mab
safe
human
trial
immun
still
improv
respons
rsv
infect
antifus
f
protein
antiattach
glycoprotein
g
main
antibodi
produc
cell
contribut
rsv
clearanc
murin
model
lung
trm
protect
effect
human
rsv
challeng
vaccin
current
avail
rsv
although
mani
approach
broadli
protect
vaccin
discuss
vaccin
mice
recombin
fusion
protein
contain
conserv
region
g
rsva
rsvb
strain
result
iga
igg
antibodi
specif
rsva
rsvb
g
protein
vaccin
protect
mice
challeng
rsva
rsvb
calf
anim
model
closer
rsv
infect
human
taylor
et
al
vaccin
calv
viral
vector
express
sequenc
f
n
protein
human
rsv
hrsv
vaccin
induc
neutral
antibodi
well
cell
calv
protect
heterolog
bovin
rsv
brsv
challeng
possibl
crossreact
sinc
hrsv
brsv
high
degre
sequenc
homolog
crossreact
human
antibodi
also
detect
two
epitop
g
protein
rsva
rsvb
human
igg
antibodi
show
neutral
effect
virus
cell
cultur
furthermor
human
mab
crossneutr
rsv
human
metapneumoviru
hmpv
identifi
one
mab
also
react
two
paramyxovirus
protect
effect
upon
infect
aforement
virus
murin
model
describ
infect
rv
gener
serotypespecif
antibodi
prevent
infect
serotyp
sinc
distinct
rv
strain
character
date
reinfect
strain
common
viral
capsid
protein
vp
rv
contain
sequenc
cell
epitop
conserv
across
strain
therefor
humor
cellular
crossreact
might
provid
crossstrain
protect
heterolog
rv
infect
immun
promot
adjuv
protect
mice
heterolog
challeng
cell
preferenti
expand
lung
cell
immun
mice
show
increas
product
compar
control
upon
stimul
heterolog
peptid
immun
also
enhanc
neutral
antibodi
heterolog
rv
challeng
crossreact
antibodi
especi
rva
c
detect
human
limit
might
aris
fact
antibodi
bind
nonprotect
epitop
might
lead
immun
escap
rv
seroneg
healthi
human
cell
epitop
co
cultur
dc
cell
result
prolifer
cell
enhanc
product
muehl
et
al
show
preexist
tm
cell
specif
conserv
epitop
vp
region
prolifer
upon
challeng
seroneg
donor
tm
cell
mainli
show
follicular
helper
phenotyp
furthermor
cell
also
recogn
epitop
result
suggest
tm
cell
specif
conserv
rv
region
may
mediat
heterolog
protect
conserv
sequenc
might
use
peptid
vaccin
could
especi
use
asthmat
copd
patient
ebv
caus
pathogen
infecti
mononucleosi
im
diseas
sever
vari
substanti
children
usual
show
mild
symptom
wherea
adolesc
adult
often
present
sever
symptom
reactiv
cell
crossreact
ebv
bamhi
fragment
leftward
open
read
frame
epitop
shown
contribut
lymphoprolifer
im
tab
addit
frequenc
tetram
cell
correl
im
diseas
sever
associ
differ
tcr
repertoir
usag
enhanc
product
other
found
bystand
activ
expans
ivspecif
cell
im
cell
human
donor
shown
recogn
two
ivderiv
two
ebvderiv
epitop
privat
tcr
repertoir
usag
might
explain
differ
number
peptid
recogn
cell
donor
recent
data
suggest
cell
crossreact
bamhi
r
fragment
leftward
open
read
frame
protect
adult
primari
ebv
infect
seroneg
statu
associ
usag
privat
oligoclon
tcr
repertoir
higher
frequenc
cell
author
specul
crossreact
trm
might
prevent
primari
ebv
infect
b
cell
tonsil
acut
hcv
infect
variabl
symptom
rang
asymptomat
sever
diseas
restrict
nonstructur
protein
epitop
hcv
target
cell
hcv
infect
cell
detect
blood
hcv
posit
donor
also
hcv
seroneg
hcvsn
donor
analysi
show
first
cell
crossreact
ivderiv
epitop
second
iv
infect
induc
hcv
specif
cell
anoth
studi
found
crossreact
epitop
weak
recognit
epitop
depend
preced
hcv
infect
cell
shown
crossreact
cytomegaloviru
cmv
epsteinbarr
viru
ebv
deriv
iv
epitop
vitro
therefor
cell
might
origin
infect
one
virus
preexist
cellular
immun
toward
epitop
either
result
enhanc
immun
shown
evalu
hcv
peptid
vaccin
trial
detriment
effect
shown
urbani
et
al
tab
latter
found
patient
sever
hcv
liver
diseas
use
privat
tcr
repertoir
cell
crossreact
epitop
patient
cell
respons
narrowli
focus
epitop
adenovirus
ad
known
potenti
viral
vector
vaccin
infect
also
util
gene
therapi
inocul
ad
serotyp
mice
induc
robust
humor
cellular
immun
multipl
hcv
peptid
vitro
result
enhanc
viru
clearanc
moreov
hcvsn
donor
preexist
ad
immun
show
crossreact
humor
cellular
immun
toward
hcv
peptid
studi
need
determin
possibl
use
ad
develop
vaccin
hcv
limit
may
aris
preexist
ad
immun
possibl
lead
lack
respons
vaccin
cell
crossreact
detect
restrict
epitop
vitro
among
hiv
seroposit
seroneg
donor
tab
crossreact
weak
seroneg
donor
suggest
strong
cell
respons
necessari
induc
reactiv
cell
larger
cohort
studi
hiv
seroposit
subject
confirm
iv
crossreact
cell
hiv
individu
frequent
target
epitop
vitro
show
cell
specif
epitop
vitro
effect
iv
hiv
crossreact
cell
cours
hiv
infect
could
detect
adenovir
vector
use
form
hiv
vaccin
avoid
format
strain
specif
antibodi
rare
adenoviru
strain
util
unfortun
also
preexist
cellular
immun
adenovir
vector
imped
success
vaccin
frahm
et
al
show
preexist
cell
led
decreas
number
hivspecif
cell
narrow
cell
respons
upon
hiv
vaccin
human
addit
extens
cell
crossreact
adenoviru
strain
shown
furthermor
hivcrossreact
tm
cell
detect
unexpos
adult
complic
predict
antihiv
immun
high
risk
hpv
type
other
main
risk
factor
multipl
genit
cancer
nilg
et
al
describ
crossreact
epitop
hpv
type
epitop
human
cov
tab
hpv
cell
found
patient
cervic
cancer
even
often
healthi
blood
donor
cell
healthi
donor
possibl
form
cov
infect
whether
cell
crossreact
neg
effect
antitumor
immun
might
support
tumor
clearanc
remain
determin
preexist
tm
cell
show
expans
season
iv
vaccin
tm
cell
expand
stimul
trichomona
vaginali
vaginali
deriv
hypothet
finegoldia
magna
f
magna
deriv
hypothet
peptid
vitro
tab
cell
one
donor
recogn
peptid
wherea
donor
cell
recogn
f
magna
peptid
furthermor
two
peptid
stimul
differ
ivreact
cell
clone
distinct
affin
find
might
result
first
differenti
shape
hi
base
encount
divers
pathogen
second
fact
hi
necessarili
reciproc
oral
liveattenu
salmonella
typhi
strain
vaccin
induc
increas
influenzareact
cell
duoden
mucosa
healthi
adult
home
marker
upregul
influenzareact
cell
studi
need
better
determin
mechan
behind
increas
influenzaspecif
cell
duoden
mucosa
adem
preced
either
infect
case
vaccin
case
episod
infect
vaccin
relat
adem
may
also
occur
patient
hmpv
parainfluenza
iv
infect
iv
vaccin
preced
adem
report
influenza
infect
shown
trigger
exacerb
diseas
experiment
autoimmun
encephalomyel
eae
model
might
use
studi
adem
patient
affect
adem
myelin
basic
protein
mbp
reactiv
cell
well
differ
neuron
antibodi
includ
antimyelin
oligodendrocyt
protein
mog
detect
gener
autoreact
cell
antibodi
probabl
due
molecular
mimicri
tcr
crossreact
mbpmogderiv
respiratori
virusderiv
epitop
shown
coronaviru
adenoviru
influenza
viru
ha
epitop
tab
antimog
antibodi
frequent
found
adem
might
pathogen
role
sinc
induc
demyelin
diseas
eae
anim
model
gb
case
thought
infectionrel
frequent
gastrointestin
respiratori
tract
infect
includ
influenza
molecular
mimicri
antibodi
pathogenderiv
selfantigen
seem
play
major
role
initi
gb
best
describ
campylobact
jejuni
recent
metaanalysi
found
slight
signific
increas
rel
risk
influenza
vaccineassoci
gb
among
studi
publish
other
found
increas
diseas
risk
link
influenza
infect
subsequ
develop
gb
better
establish
mechan
influenza
influenzavaccineinduc
gb
larg
remain
unknown
first
clue
might
find
nachamkin
et
al
show
vaccin
well
trival
vaccin
season
induc
antiha
also
antibodi
mice
immun
addit
vaccin
contain
glycolipidlik
structur
shown
posit
immunostain
antibodi
show
low
detect
hemagglutin
inhibit
activ
narcolepsi
associ
iv
vaccin
glaxosmithklin
london
uk
also
infect
recent
ahm
et
al
show
vaccin
individu
induc
iv
antibodi
crossreact
hypocretin
receptor
tab
although
hypocretin
receptor
autoantibodi
detect
patient
narcolepsi
exact
mechan
antibodyinduc
narcolepsi
remain
determin
autoantibodi
potenti
link
narcolepsi
antimonosialodihexosylgangliosid
antitribbl
homolog
antibodi
antibodi
detect
frequent
patient
narcolepsi
vaccin
healthi
control
wherea
correl
evid
antibodi
vaccin
nonetheless
antibodi
titer
found
increas
narcolepsi
patient
compar
control
furthermor
transfer
pool
posit
igg
sampl
blood
narcolepsi
patient
mice
result
narcolepsylik
symptom
orexinneuron
loss
antinmethyldaspart
receptor
nmdar
antibodi
detect
patient
herp
simplex
enceph
although
result
inconsist
find
suggest
infect
possibl
trigger
psychiatr
diseas
matern
infect
includ
influenza
suggest
play
role
develop
psychiatr
disord
child
lucches
et
al
identifi
influenza
epitop
mimic
multipl
neuron
protein
tab
crossreact
might
lead
neuropsychiatr
disord
although
experiment
verif
need
autoantibodi
may
play
role
neuropsychiatr
disord
anorexia
nervosa
chronic
fatigu
syndrom
major
depress
antiadrenocorticotropin
acth
antibodi
may
caus
acth
defici
wheatland
propos
sarscov
infect
induc
pathogenspecif
antibodi
crossreact
acth
tab
gastrointestin
infect
lesser
extent
also
respiratori
infect
earli
life
increas
risk
develop
cd
ad
may
contribut
cd
develop
sequenc
mimic
agliadin
identifi
kilodalton
kda
protein
ad
rat
antiserum
gener
epitop
crossreact
agliadin
well
synthet
peptid
tabl
cd
patient
serum
antibodi
also
shown
react
synthet
peptid
furthermor
cell
crossreact
synthet
peptid
resembl
sequenc
detect
cd
patient
result
inconsist
followup
studi
infecti
myocard
caus
differ
pathogen
includ
respiratori
virus
ad
iv
rsv
cv
viral
immun
mechan
contribut
diseas
onset
persist
myocard
massilamani
et
al
show
immun
aj
mice
peptid
mimic
cardiac
myosin
heavi
chain
myhc
induc
crossreact
cell
led
develop
myocard
addit
cv
infect
led
gener
cell
associ
myocard
aj
mice
tab
differ
antibodi
includ
cardiac
myosin
actin
associ
myocard
cv
mimic
sequenc
actin
myosin
collagen
laminin
moreov
anticv
antibodi
shown
bind
actin
collagen
iv
fibronectin
viral
infect
includ
cv
suggest
play
role
develop
ss
ss
antibodi
andor
cell
differ
autoantigen
frequent
ro
ssa
la
ssb
present
sequenc
homolog
protein
cv
kda
antigen
may
induc
crossreact
autoantibodi
stathopoul
et
al
show
serum
ss
patient
recogn
synthet
peptid
homolog
region
protein
frequent
serum
system
lupu
erythematosu
sle
patient
control
crossreact
confirm
inhibit
assay
use
synthet
peptid
tab
mimic
kda
cell
epitop
identifi
variou
bacteria
human
skin
oral
caviti
intestin
vagin
flora
peptid
mimic
abl
stimul
kdareact
cell
develop
link
differ
viral
infect
especi
enteroviru
infect
also
respiratori
viral
infect
includ
iv
may
associ
one
possibl
mechan
contribut
autoimmun
molecular
mimicri
cmv
rotaviru
infect
may
induc
crossreact
cell
pancreat
autoantigen
wherea
coxsacki
viru
cv
find
inconsist
recent
qi
et
al
stain
pancreat
tissu
monoclon
antibodi
specif
differ
influenza
ha
epitop
two
distinct
antibodi
crossreact
human
pancreat
tab
shown
mice
almost
complet
diphtheria
toxininduc
loss
pancreat
cell
abl
differenti
insulin
produc
cell
pancreat
cell
progenitor
influenzainduc
antibodi
antigen
eventu
result
onset
diabet
million
peopl
current
affect
asthma
worldwid
preval
might
rise
billion
characterist
asthma
chronic
airway
inflamm
airway
hyperreact
product
mucu
remodel
airway
becom
relev
particularli
chronic
diseas
one
major
risk
factor
develop
asthma
recurr
wheez
episod
earli
life
caus
virus
case
rsvor
rvinduc
wheez
children
year
least
one
asthmat
parent
associ
increas
risk
asthma
year
age
recent
lukkarinen
et
al
follow
children
sever
wheez
episod
year
identifi
rvinduc
wheez
sensit
eczema
risk
factor
develop
atop
asthma
wherea
nonatop
asthma
risk
factor
includ
first
wheez
month
age
caus
virus
rvrsv
parent
smoke
earli
onset
asthma
resolv
spontan
recurr
infect
respiratori
virus
time
make
spontan
resolut
less
like
therefor
viral
respiratori
tract
infect
also
contribut
persist
asthma
asthma
exacerb
also
caus
respiratori
viral
infect
rv
rsv
iv
cov
hmpv
parainfluenza
viru
adenoviru
rv
pathogen
detect
frequent
age
group
wherea
rsv
affect
mostli
preschool
children
iv
preval
adult
hand
prevail
concept
explain
rise
preval
allerg
autoimmun
diseas
industri
countri
hygien
hypothesi
accord
latter
less
frequent
exposur
pathogen
earli
life
associ
develop
allergi
protect
effect
bacteria
bacteri
product
asthma
develop
well
character
also
virus
well
respiratori
virus
includ
iv
shown
protect
mice
asthma
correl
protect
induct
immun
respons
eg
stimul
innat
immun
receptor
tolllik
receptor
viral
infect
shown
protect
asthma
induct
natur
killer
nkt
cell
subset
monocyt
regulatori
phenotyp
group
examin
role
respiratori
viral
infect
asthma
protect
murin
model
agreement
earlier
report
found
iv
infect
balbc
mice
confer
protect
ovalbumin
ova
induc
also
hous
dust
mite
hdm
induc
asthma
protect
depend
tem
cell
crossreact
iv
ovaderiv
peptid
predict
bioinformat
analysi
upon
ex
vivo
restimul
predict
influenza
ovaderiv
peptid
lung
cell
show
increas
product
furthermor
peptid
immun
predict
virusderiv
peptid
also
provid
asthma
protect
tem
cell
possibl
due
product
virusspecif
cell
upon
allergen
challeng
augment
ifn
respons
protect
experiment
asthma
thu
provid
evid
temmedi
hi
virus
allergen
protect
mechan
allerg
asthma
fig
hi
involv
respiratori
virus
may
variou
protect
also
detriment
effect
host
differ
privat
tcr
repertoir
clinic
outcom
crossreact
epitop
may
detriment
one
benefici
anoth
person
seen
exampl
iv
ebv
iv
vaccin
associ
autoimmun
diseas
case
nevertheless
associ
autoimmun
diseas
respiratori
viral
infect
extens
discuss
differ
approach
broadli
protect
vaccin
current
investig
vaccin
shown
induc
lung
trm
cell
role
heterolog
protect
respiratori
tract
infect
yet
determin
human
group
show
hi
respiratori
virus
allergen
protect
experiment
asthma
thu
expand
hygien
hypothesi
studi
need
determin
whether
hi
broadli
applic
concept
respiratori
virus
environment
allergen
moreov
interest
see
whether
current
licenc
futur
vaccin
potenti
induc
heterolog
protect
viral
infect
well
asthma
recent
gammaherpesviru
infect
shown
induc
regulatori
monocyt
prevent
experiment
asthma
mice
therefor
heterolog
innat
immun
stimul
tolerogen
promot
adjuv
might
utilis
induc
allergen
toler
fig
acut
dissemin
encephalomyel
adem
adem
rare
autoimmun
diseas
affect
central
nervou
system
cn
incid
peopleyear
especi
young
children
suffer
adem
adult
may
also
affect
adem
autoimmun
mediat
demyelin
diseas
central
nervou
system
cn
usual
monophas
cours
clinic
vast
array
neurolog
symptom
possibl
vari
focal
deficit
encephalopathi
confus
reduc
conscious
irrit
antinmethyldaspart
receptor
nmdar
enceph
antinmethyldaspart
receptor
nmdar
enceph
belong
heterogen
group
autoimmun
epilepsi
mainli
occur
paraneoplast
syndrom
antibodi
direct
cancer
antigen
thought
crossreact
neuron
antigen
celiac
diseas
cd
preval
cd
european
popul
approxim
genet
suscept
individu
genet
background
andor
usual
develop
symptom
childhood
although
diseas
onset
may
occur
later
life
differ
infect
thought
promot
prevent
cd
develop
comput
optim
broadli
reactiv
antigen
cobra
ha
ha
amino
acid
composit
mani
isol
iv
strain
analys
aim
defin
consensu
sequenc
everi
amino
acid
ha
protein
syndrom
gb
gb
rare
neurolog
diseas
incid
peopl
per
year
classic
gb
also
call
acut
inflammatori
demyelin
polyneuropathi
aidp
caus
autoimmun
demyelin
peripher
nerv
lead
subacut
ascend
paralysi
muscl
weak
sensori
deficit
limb
sever
case
present
respiratori
failur
autonom
instabl
axon
form
gb
name
aman
amsan
associ
andor
anti
antibodi
miller
fisher
syndrom
lesser
extent
also
bickerstaff
brainstem
enceph
antibodi
found
antibodi
specif
aidp
detect
yet
heterolog
innat
immun
stimul
origin
homolog
pathogenantigen
often
induc
adapt
immun
respons
heterolog
pattern
recognit
receptor
prr
ligand
stem
sourc
origin
antigen
mostli
induc
adapt
immun
respons
heterolog
prr
stimul
alter
immun
respons
toward
homolog
antigen
prr
ligand
includ
variou
substanc
vaccin
adjuv
pathogen
commens
bacteria
endogen
ligand
eg
hyaluron
acid
heterosubtyp
immun
immun
toward
one
viru
also
provid
heterolog
immun
substrain
first
viru
term
heterosubtyp
immun
mostli
use
refer
iv
infect
heterolog
immun
hi
immun
respons
toward
one
antigen
alter
immun
respons
toward
subsequ
encount
unrel
antigen
involv
allo
auto
allergenderiv
antigen
well
pathogenderiv
antigen
heterolog
antigen
encount
may
protect
detriment
effect
host
myocard
initi
phase
diseas
thought
mediat
direct
myocardi
damag
distinct
agent
eg
infect
toxin
drug
follow
immun
mediat
phase
ongo
infect
andor
autoimmun
diseas
lead
chronic
myocard
myocard
result
dilat
cardiomyopathi
sudden
cardiac
death
narcolepsi
narcolepsi
character
daytim
sleepi
cataplexi
sleep
attack
affect
per
peopl
loss
hypocretin
orexin
produc
neuron
hypothalamu
characterist
type
narcolepsi
type
narcolepsi
diseas
onset
typic
year
age
patient
narcolepsi
cataplexi
posit
suggest
role
cell
diseas
pathogenesi
monoval
vaccin
broadli
use
europ
swine
flu
pandem
pandemrix
contain
much
higher
dose
np
vaccin
paratop
antigen
bind
region
antibodi
contain
multipl
paratop
recogn
epitop
given
antigen
privat
tcr
repertoir
public
tcr
repertoir
consist
cell
clone
ident
individu
wherea
cell
clone
uniqu
individu
form
privat
tcr
repertoir
privat
tcr
repertoir
lead
variabl
immun
recognit
crossreact
phenomena
exampl
recognit
epitop
differ
cell
may
result
detriment
benefici
diseas
outcom
respect
host
syndrom
ss
ss
character
lymphocyt
infiltr
salivari
gland
sgl
decreas
sgl
function
caus
xerostomia
xerophthalmia
cell
receptor
tcr
crossreact
abil
tcr
recogn
one
antigen
refer
tcr
crossreact
type
diabet
mellitu
character
autoimmun
mediat
loss
insulinproduc
cell
pancrea
glucagonproduc
cell
somatostatin
produc
cell
spare
diseas
thought
cell
mediat
mean
autoreact
cell
attack
pancreat
cell
